ArticleDiagnostics (Basel, Switzerland)2022
Development of a Machine Learning Based Web Application for Early Diagnosis of COVID-19 Based on Symptoms.
Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Smart decision support system for keratoconus severity staging using corneal curvature and thinnest pachymetry indices.Eye and vision (London, England) · 2024Article
- Deep learning approach for early prediction of COVID-19 mortality using chest X-ray and electronic health records.BMC bioinformatics · 2023Article
- Graph data science and machine learning for the detection of COVID-19 infection from symptoms.PeerJ. Computer science · 2023Article
- A Semi-Supervised Machine Learning Approach in Predicting High-Risk Pregnancies in the Philippines.Diagnostics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Detecting the presence of a disease requires laboratory tests, testing kits, and devices; however, these were not always available on hand. This study proposes a new approach in disease detection using machine learning algorithms by analyzing symptoms experienced by a person without requiring laboratory tests. Six supervised machine learning algorithms such as J48 decision tree, random forest, support vector machine, k-nearest neighbors, naïve Bayes algorithms, and artificial neural networks were applied in the "COVID-19 Symptoms and Presence Dataset" from Kaggle. Through hyperparameter optimization and 10-fold cross validation, we attained the highest possible performance of each algorithm. A comparative analysis was performed according to accuracy, sensitivity, specificity, and area under the ROC curve. Results show that random forest, support vector machine, k-nearest neighbors, and artificial neural networks outweighed other algorithms by attaining 98.84% accuracy, 100% sensitivity, 98.79% specificity, and 98.84% area under the ROC curve. Finally, we developed a web application that will allow users to select symptoms currently being experienced, and use it to predict the presence of COVID-19 through the developed prediction model. Based on this mechanism, the proposed method can effectively predict the presence or absence of COVID-19 in a person immediately without using laboratory tests, kits, and devices in a real-time manner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.